Multinational drug firms post brisk sales

Foreign drug manufacturers in the local market have been on the receiving end of a sales bonanza since medical reforms were instituted three years ago, whereas Korean drug manufacturers are on edge.

Rep. Kim Hong-shin, a committee member of Health and Welfare of the National Assembly, said in his report on April 21 that eight foreign drugs represented the top ten health insurance all...